Australia Facial Injectable Market Size, Share & Trends Analysis Report By Product (Hyaluronic Acid, Botulinum Toxin Type A), By Application (Aesthetics, Therapeutics), And Segment Forecast, 2022 - 2030
This report can be delivered to the clients within 3 Business Days
Australia Facial Injectable Market Growth & Trends
The Australia facial injectable market size is expected to reach USD 22.8 billion by 2030, according to a new report by Grand View Research, Inc., registering a CAGR of 26.4% over the forecast period. Facial Injectable is used to reduce wrinkles and fine lines, create volume and shaping, as well as build facial framework and structure. The rising awareness regarding cosmetic procedures and a rise in the elderly population are two key reasons predicted to propel the industry growth. In addition, developments in facial rejuvenation and the trend shift from invasive to minimally invasive procedures are other drivers anticipated to promote market growth over the projection period.
Dermatologists and other professionals can treat various facial areas, personalize treatments for each patient, and utilize a combination of products to get better results. These factors are anticipated to support the expansion of the market in Australia during the forecast period. Peer recommendations have a significant impact on millennials’ purchasing decisions, which are greatly influenced by social media. According to the Yellow Social Media Report 2020, 63% of Australians claimed that endorsements from celebrities or social media influencers make them less likely to make a purchase, while 15% of them said the opposite. In addition, according to the Mission Australia Youth Survey Report 2018, roughly 30.4% of participants expressed concern about their body image.
This, in turn, will increase the demand for cosmetic treatments, leading to market growth. The COVID-19 outbreak led to an increase in internet consultations. Australia undertook a widespread temporary closure of beauty and cosmetic services as a preventative action against COVID-19. The Centre for Mental Health at Swinburne University has been conducting research on how the closure of the beauty business has affected Australians’ mental health. According to the study, compared to before COVID-19, the general population reported having less interest in having cosmetic surgery or treatment after the end of the first lockdown in May, this, in turn, impacted the demand for facial injectables.
Australia Facial Injectable Market Report Highlights
Australia Facial Injectable Market Growth & Trends
The Australia facial injectable market size is expected to reach USD 22.8 billion by 2030, according to a new report by Grand View Research, Inc., registering a CAGR of 26.4% over the forecast period. Facial Injectable is used to reduce wrinkles and fine lines, create volume and shaping, as well as build facial framework and structure. The rising awareness regarding cosmetic procedures and a rise in the elderly population are two key reasons predicted to propel the industry growth. In addition, developments in facial rejuvenation and the trend shift from invasive to minimally invasive procedures are other drivers anticipated to promote market growth over the projection period.
Dermatologists and other professionals can treat various facial areas, personalize treatments for each patient, and utilize a combination of products to get better results. These factors are anticipated to support the expansion of the market in Australia during the forecast period. Peer recommendations have a significant impact on millennials’ purchasing decisions, which are greatly influenced by social media. According to the Yellow Social Media Report 2020, 63% of Australians claimed that endorsements from celebrities or social media influencers make them less likely to make a purchase, while 15% of them said the opposite. In addition, according to the Mission Australia Youth Survey Report 2018, roughly 30.4% of participants expressed concern about their body image.
This, in turn, will increase the demand for cosmetic treatments, leading to market growth. The COVID-19 outbreak led to an increase in internet consultations. Australia undertook a widespread temporary closure of beauty and cosmetic services as a preventative action against COVID-19. The Centre for Mental Health at Swinburne University has been conducting research on how the closure of the beauty business has affected Australians’ mental health. According to the study, compared to before COVID-19, the general population reported having less interest in having cosmetic surgery or treatment after the end of the first lockdown in May, this, in turn, impacted the demand for facial injectables.
Australia Facial Injectable Market Report Highlights
- The botulinum toxin type A product segment dominated the overall industry in 2021 and will remain dominant throughout the forecast period
- The use of botulinum toxins for medicinal purposes has made room for the expansion in the healthcare industry
- The aesthetics segment led the market and accounted for the maximum revenue share in 2021
- The segment growth can be attributed to the rising spending on aesthetic procedures and rising consumer awareness about these procedures
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market Segmentation & Scope
1.1.1 Product Type
1.1.2 Application
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective -
1.10.2 Objective -
1.10.3 Objective -
1.10.4 Objective -
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
CHAPTER 3 AUSTRALIA FACIAL INJECTABEL MARKET: VARIABLES, TRENDS, & SCOPE
3.1 Market Segmentation and Scope
3.2 Market Lineage Outlook
3.2.1 Parent Market Outlook
3.2.2 Related/Ancillary Market Outlook
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.2.1 Increasing beauty consciousness among people
3.3.2.2 Shift in consumer preference for minimally invasive procedures
3.3.2.3 Growing population aged between 25 and 65 years
3.3.2 Market Restraint Analysis
3.3.2.1 Adverse Effects Associated With Certain Facial Injectables
3.4 Penetration & Growth Prospect Mapping
3.5 Market Analysis Tools
3.5.1 Industry Analysis - Porter’s
3.5.2 Pestel Analysis
3.6 Reimbursement Policies
CHAPTER 4 AUSTRALIA FACIAL INJECTABLE MARKET: PRODUCT SEGMENT ANALYSIS
4.1 Australia Facial Injectable: Product Market Share Analysis, 2021 & 2030
4.2 Collagen
4.2.1 Collagen Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
4.3 Hyaluronic Acid (HA)
4.3.1. Hyaluronic Adic (HA) Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
4.4 Botulinum Toxin Type A
4.4.1 Botulinum Toxin Type A Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
4.5 Calcium Hydroxylapatite
4.5.1 Calcium Hydroxylapatite Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
4.6 Polymer Fillers
4.6.1 Polymer Fillers Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
CHAPTER 5 AUSTRALIA FACIAL INJECTABLE MARKET: APPLICATION SEGMENT ANALYSIS
5.1 Australia Facial injectable: Application Market Share Analysis, 2021 & 2030
5.2 Therapeutics
5.2.1 Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
5.3 Aesthetics
5.3.1 Aesthetics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
CHAPTER 6 COMPANY PROFILES
6.1.1 SILK LASER CLINICS
6.1.1.1 Company overview
6.1.1.2 Financial performance
6.1.1.3 Product benchmarking
6.1.1.4 Strategic initiatives
6.1.2 ADVANCED CLINICS AUSTRALIA
6.1.2.1 Company overview
6.1.2.2 Financial performance
6.1.2.3 Product Benchmarking
6.1.2.4 Strategic initiatives
6.1.3 RESULTS LASER CLINIC
6.1.3.1 Company overview
6.1.3.2 Financial performance
6.1.3.3 Product benchmarking
6.1.3.4 Strategic initiatives
6.1.4 AUSTRALIAN SKIN CLINICS
6.1.4.1 Company overview
6.1.4.2 Financial performance
6.1.4.3 Strategic initiatives
6.1.5 LASER CLINICS AUSTRALIA
6.1.5.1 Company overview
6.1.5.2 Financial performance
6.1.5.3 Product benchmarking
6.1.5.4 Strategic initiatives
1.1 Market Segmentation & Scope
1.1.1 Product Type
1.1.2 Application
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective -
1.10.2 Objective -
1.10.3 Objective -
1.10.4 Objective -
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
CHAPTER 3 AUSTRALIA FACIAL INJECTABEL MARKET: VARIABLES, TRENDS, & SCOPE
3.1 Market Segmentation and Scope
3.2 Market Lineage Outlook
3.2.1 Parent Market Outlook
3.2.2 Related/Ancillary Market Outlook
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.2.1 Increasing beauty consciousness among people
3.3.2.2 Shift in consumer preference for minimally invasive procedures
3.3.2.3 Growing population aged between 25 and 65 years
3.3.2 Market Restraint Analysis
3.3.2.1 Adverse Effects Associated With Certain Facial Injectables
3.4 Penetration & Growth Prospect Mapping
3.5 Market Analysis Tools
3.5.1 Industry Analysis - Porter’s
3.5.2 Pestel Analysis
3.6 Reimbursement Policies
CHAPTER 4 AUSTRALIA FACIAL INJECTABLE MARKET: PRODUCT SEGMENT ANALYSIS
4.1 Australia Facial Injectable: Product Market Share Analysis, 2021 & 2030
4.2 Collagen
4.2.1 Collagen Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
4.3 Hyaluronic Acid (HA)
4.3.1. Hyaluronic Adic (HA) Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
4.4 Botulinum Toxin Type A
4.4.1 Botulinum Toxin Type A Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
4.5 Calcium Hydroxylapatite
4.5.1 Calcium Hydroxylapatite Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
4.6 Polymer Fillers
4.6.1 Polymer Fillers Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
CHAPTER 5 AUSTRALIA FACIAL INJECTABLE MARKET: APPLICATION SEGMENT ANALYSIS
5.1 Australia Facial injectable: Application Market Share Analysis, 2021 & 2030
5.2 Therapeutics
5.2.1 Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
5.3 Aesthetics
5.3.1 Aesthetics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
CHAPTER 6 COMPANY PROFILES
6.1.1 SILK LASER CLINICS
6.1.1.1 Company overview
6.1.1.2 Financial performance
6.1.1.3 Product benchmarking
6.1.1.4 Strategic initiatives
6.1.2 ADVANCED CLINICS AUSTRALIA
6.1.2.1 Company overview
6.1.2.2 Financial performance
6.1.2.3 Product Benchmarking
6.1.2.4 Strategic initiatives
6.1.3 RESULTS LASER CLINIC
6.1.3.1 Company overview
6.1.3.2 Financial performance
6.1.3.3 Product benchmarking
6.1.3.4 Strategic initiatives
6.1.4 AUSTRALIAN SKIN CLINICS
6.1.4.1 Company overview
6.1.4.2 Financial performance
6.1.4.3 Strategic initiatives
6.1.5 LASER CLINICS AUSTRALIA
6.1.5.1 Company overview
6.1.5.2 Financial performance
6.1.5.3 Product benchmarking
6.1.5.4 Strategic initiatives
LIST OF TABLES
Table 1 List of secondary sources
Table 2 List of Abbreviations
Table 3 Strategic collaborations by key players
Table 1 List of secondary sources
Table 2 List of Abbreviations
Table 3 Strategic collaborations by key players
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity flow analysis
Fig. 9 Australia facial injecatble market snapshot (2021)
Fig. 10 Australia facial injecatble market segmentation
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Porter’s five forces analysis
Fig. 15 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 16 Australia facial injecatble market product outlook: Segment dashboard
Fig. 17 Australia facial injecatble market: product movement analysis
Fig. 18 Collagen market, 2018 - 2030 (USD Billion)
Fig. 19 Hyaluronic acid market, 2018 - 2030 (USD Billion)
Fig. 20 Botulinum toxin type A market, 2018 - 2030 (USD Billion)
Fig. 21 Calcium hydroxylapatite (CaHA) market, 2018 - 2030 (USD Billion)
Fig. 22 Polymer Fillers market, 2018 - 2030 (USD Billion)
Fig. 23 Australia facial injectable market application outlook: Segment dashboard
Fig. 24 Australia facial injectable market: Application movement analysis
Fig. 25 Therapeutics market, 2018 - 2030 (USD Billion)
Fig. 26 Aesthetics market, 2018 - 2030 (USD Billion)
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity flow analysis
Fig. 9 Australia facial injecatble market snapshot (2021)
Fig. 10 Australia facial injecatble market segmentation
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Porter’s five forces analysis
Fig. 15 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 16 Australia facial injecatble market product outlook: Segment dashboard
Fig. 17 Australia facial injecatble market: product movement analysis
Fig. 18 Collagen market, 2018 - 2030 (USD Billion)
Fig. 19 Hyaluronic acid market, 2018 - 2030 (USD Billion)
Fig. 20 Botulinum toxin type A market, 2018 - 2030 (USD Billion)
Fig. 21 Calcium hydroxylapatite (CaHA) market, 2018 - 2030 (USD Billion)
Fig. 22 Polymer Fillers market, 2018 - 2030 (USD Billion)
Fig. 23 Australia facial injectable market application outlook: Segment dashboard
Fig. 24 Australia facial injectable market: Application movement analysis
Fig. 25 Therapeutics market, 2018 - 2030 (USD Billion)
Fig. 26 Aesthetics market, 2018 - 2030 (USD Billion)
